Abstract. We investigated whether p42 / p44 mitogen-activated protein kinase (MAPK) and / or p38 MAPK participates in the regulation of vascular smooth muscle contraction by endothelin-1 (ET-1) in Wistar-Kyoto rat (WKY) and spontaneously hypertensive rat (SHR). ET-1 (10 nM) induced a sustained contraction in WKY and SHR aortas. PD98059 (100 m M), an inhibitor of p42/ p44 MAPK kinase, partially attenuated the ET-1-induced contraction in WKY and SHR. However, SB203580 (10 m M), an inhibitor of p38 MAPK, relaxed the ET-1-induced contraction to the resting levels in SHR, but not in WKY. ET-1 (10 nM) increased phosphorylation of both p42 / p44 MAPK and p38 MAPK in WKY and SHR. However, in SHR, p38 MAPK phosphorylation in response to ET-1 stimulation was increased more than in WKY. PD98059 (100 m M) and SB203580 (10 m M) abolished the phosphorylation of p42 / p44 MAPK and p38 MAPK in response to ET-1 stimulation in WKY and SHR, respectively. On the other hand, SB203580 (10 mM) did not affect myosin light chain (MLC) phosphorylation in response to ET-1 (10 nM) stimulation in WKY and SHR. From these results, it is concluded that p42 / p44 MAPK and/ or p38 MAPK partially regulates the ET-1-induced vasoconstriction in WKY. However, p38 MAPK, rather than p42 / p44 MAPK, activation plays an important role for the maintenance of ET-1-induced vasoconstriction in SHR through a MLC phosphorylationindependent pathway.
Introduction
An increase of peripheral resistance due to enhanced vascular response is a major factor that increases blood pressure in humans. Endothelin-1 (ET-1), a potent vasoconstrictor derived from blood vessel endothelium (1) , may also participate in human essential hypertension (2) . Besides hypertension, ET-1 may be involved in other cardiovascular diseases, including myocardial infarction, congestive heart failure, restenosis, and atherosclerosis (3) . There are several reported mechanisms through which vascular smooth muscle contractions are evoked by ET-1. Increases in the sensitivity of the muscle contractile apparatus to intracellular Ca
as well as to increases of [Ca

2+
] i , may be involved in ET-1-induced vasoconstriction (4 -9) .
In mammals, members of the mitogen-activated protein kinase (MAPK) family include extracellular signal-regulated kinases (ERKs) 1 / 2, NH 2 -terminal Jun kinase / stress-activated protein kinases (JNK/ SAPK) and p38 MAPKs (10) . ERK1 and ERK2 are 44-and 42-kDa enzymes, respectively and are acutely stimulated by growth and differentiation factors. On the other hand, JNK / SAPK and p38 MAPK are implicated in responses to cellular stress, inflammation, and apoptosis. p42 / p44 MAPK may play a role in vascular smooth muscle contraction (11) . Moreover, p42 / p44 MAPK may be an important regulator for rabbit basilar artery contraction (12) . In contrast, p42 / p44 MAPK is † These authors contributed equally to this work. *Corresponding author. FAX: +82 43 272 1603 E-mail: hyahn@chungbuk.ac.kr not involved in vascular smooth muscle contraction or in myofilament sensitivity to Ca 2+ (13 -15) . The roles of p42 / p44 MAPK as well as p38 MAPK on vasoconstriction are thus still controversial.
In this study, the mechanism(s) by which p42 / p44 MAPK and p38 MAPK might regulate the ET-1-induced vascular smooth muscle contraction was investigated in Wistar-Kyoto rat (WKY) and spontaneously hypertensive rat (SHR).
Materials and Methods
Contractility
WKY (116 ± 3 mmHg, n = 25, 250 -300 g; Yonsei University Experimental Animal Center, Seoul, Korea) and SHR (185 ± 6 mmHg, n = 25, 250 -300 g; same source) were killed by 100% CO 2 inhalation. The thoracic aorta was isolated and cut into strips 8 -10 mm long and placed in physiological salt solution (PSS). Solutions were saturated with 95% O 2 and 5% CO 2 at 37°C to maintain the pH at 7.4. The force of contraction was recorded isometrically. Muscle preparations were attached to a holder under a resting force of 5 mN and equilibrated for 60 -90 min.
Myosin light chain (MLC) phosphorylation
MLC phosphorylation levels were determined on strips of the thoracic aorta as described previously (16) . Briefly, rat aortic smooth muscle homogenates prepared in urea buffer (20 mM Tris, 23 mM glycine, 8 M urea, 0.04% bromophenol blue, 10 mM DTT, pH 8.6) were subjected to urea / glycerol gel electrophoresis. Following electrophoresis, the separated proteins were subjected to high-field intensity Western blotting onto nitrocellulose membranes. Visualization of the blotted proteins was performed using an Amersham enhanced chemiluminescence (ECL) kit. Values are reported as percents by integration of the spot corresponding to the phosphorylated MLC to the total of both the phosphorylated and unphosphorylated MLC.
MAPK phosphorylation
Rat aortic smooth muscle homogenates were centrifuged at 8,000´g for 10 min at 4°C. Aliquots of 40-m g protein were subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). After electrophoresis, proteins were transferred to nitrocellulose membranes (Hybond TM-P; Amersham Biosciences, Uppsala, Sweden) for 2 -3 h at 200 mA in transfer buffer (25 mM Tris, pH 8.3, 192 mM glycine, 20% methanol). The membranes were incubated with 1 m g / mL of monoclonal anti-phospho MAP kinase (ERK 1/ 2) antibody (Upstate Biotechnology, Lake Placid, NY, USA) or polyclonal phospho-specific p38 MAP kinase antibody (New England Biolabs, Beverly, MA, USA) diluted in freshly prepared phosphate buffered saline (PBS)-milk (MLK) (overnight with agitation at 4°C). After washing the membranes twice with PBS + 0.05% Tween 20, membranes were incubated with secondary antibody (horseradish peroxidase, 1:5000 dilution) in PBS-MLK for 1.5 h at room temperature with agitation. After washing the membranes 3 -5 times in PBS + 0.05% Tween 20, immunoreactive bands were visualized using the ECL reagents. Images from ECL were scanned and analyzed using NIH Image software (http://rsb.info.nih.gov / nih-image / ).
Statistical analyses of data
Data are presented as grouped means ± standard errors of the means (S.E.M.). Statistical significance was examined with two-way ANOVA following Dunnet's Multiple Comparison Tests. A P value of <0.05 determined significance.
Results
Effect of PD98059 and SB203580 on the ET-1-induced vasoconstriction in WKY and SHR
Stimulation of the rat aortic strips with ET-1 (10 nM) resulted in a slowly developing contraction, which reached sustained levels at 20 min in both WKY and SHR. The addition of PD98059 (100 m M), an inhibitor of p42 / p44 MAPK kinase, to aortic strips contracted with ET-1 (10 nM) resulted in partial, but not complete, relaxation in WKY and SHR ( Fig. 1: A and B) . The inhibition by PD98059 (100 m M) on ET-1 (10 nM)-induced contraction was 48.9 ± 7.1% (n = 8) and 47.7 ± 4.7% (n = 8) in WKY and SHR, respectively. On the other hand, the addition of SB203580 (10 mM), an inhibitor of p38 MAPK, to aortic strips contracted with ET-1 (10 nM) resulted in partial, but not complete, relaxation in WKY ( Fig. 2A) . In contrast, the addition of SB203580 (10 m M) to aortic strips contracted with ET-1 (10 nM) resulted in relaxation to the resting levels in SHR (Fig. 2B) . The inhibition by SB203580 (10 mM) on the ET-1 (10 nM)-induced contraction was 34.6 ± 8.8% (n = 8) and 88.4 ± 4.7% (n = 8) in WKY and SHR, respectively.
Effect of PD98059 and SB203580 on the phosphorylation of p42 /p44 MAPK and p38 MAPK induced by ET-1 in WKY and SHR ET-1 (10 nM) increased phosphorylation of p42 / p44 MAPK ( Fig. 3: A and B) in both WKY and SHR. By 20 min after ET-1 stimulation, phosphorylation of p42 / p44 MAPK was increased 2.5 ± 0.2-folds (P<0.01, n = 4) and 3.1 ± 0.2-folds (P<0.01, n = 4) compared with controls in WKY and SHR, respectively. By 50 min after ET-1 stimulation, phosphorylation of p42 / p44 MAPK was increased 3.2 ± 0.2-folds (P<0.01, n = 4) and 3.5 ± 0.3-folds (P<0.01, n = 4) compared with controls in WKY and SHR, respectively. The addition of PD98059 (100 m M), an inhibitor of p42 / p44 MAPK kinase, to aortic strips stimulated with ET-1 (10 nM) resulted in inhibition of phosphorylation of p42 / p44 MAPK (P<0.01, n = 4) to the control levels in WKY and SHR, respectively.
ET-1 (10 nM) increased the phosphorylation of p38 MAPK (Fig. 4: A and B) in WKY and SHR. By 20 min after ET-1 stimulation, phosphorylation of p38 MAPK was increased 1.8 ± 0.2-folds (P<0.01, n = 5) and 2.4 ± 0.1-folds (P<0.01, n = 5) compared with controls in WKY and SHR, respectively. By 50 min after ET-1 stimulation, phosphorylation of p38 MAPK was increased 2.1 ± 0.1-folds (P<0.01, n = 5) and 2.3 ± 0.1-folds (P<0.01, n = 5) compared with controls in WKY and SHR, respectively. The addition of SB203580 (10 mM), an inhibitor of p38 MAPK, to aortic strips stimulated with ET-1 (10 nM) resulted in inhibition of phosphorylation of p38 MAPK (P<0.01, n = 5) to the control levels in both WKY and SHR, respectively.
Effect of SB203580 on the phosphorylation of MLC induced by ET-1 in WKY and SHR
ET-1 (10 nM) increased the phosphorylation of MLC (Fig. 5: A and B) in WKY and SHR. By 20 min after ET-1 stimulation, phosphorylation of MLC was increased from 19.7 ± 0.6% (n = 4) to 48.5 ± 1.0% (n = 4) (P<0.01) in WKY (Fig. 5: A and B) . By 50 min after ET-1 stimulation, phosphorylation of MLC was increased to 43.8 ± 1.8% (n = 4) (P<0.01) in WKY. The addition of SB203580 (10 mM) to aortic strips stimulated with ET-1 (10 nM) did not affect MLC phosphorylation levels (47.0% ± 2.1%, n = 4) in WKY.
On the other hand, by 20 min after ET-1 stimulation, phosphorylation of MLC was increased from 28.5 ± 0.8% (n = 4) to 45.7 ± 1.0% (n = 4) (P<0.01) in SHR (Fig. 5: A and B) . By 50 min after ET-1 stimulation, phosphorylation of MLC was increased to 43.1 ± 2.0% (n = 4) (P<0.01) in SHR (Fig. 5: A and B) . The addition of SB203580 (10 mM) to aortic strips stimulated with ET-1 (10 nM) did not affect MLC phosphorylation levels (43.5% ± 1.9%, n = 4) in SHR.
Discussion
ET acts via specific plasma membrane receptors, ET A and ET B , with distinctive characteristics for ET (17, 18) . These receptors induce smooth muscle contraction and stimulate proliferation and hypertrophy (19) . Endothelial ET B receptors also stimulate the production of nitric oxide and prostacyclin (2) . We observed that BQ-123 (0.1 m M), an antagonist of the ET A receptor, completely abolished the ET-1 (10 nM)-induced vasoconstriction in both WKY and SHR. In contrast, BQ-788 (1 mM), an antagonist of ET B receptor, did not inhibit the ET-1 (10 nM)-induced vasoconstriction in either strain (data not shown). Therefore, ET-1-induced vasoconstriction seems to be mediated by the ET A receptor rather than the ET B receptor in both WKY and SHR. PD98059 (100 m M), an inhibitor of p42 / p44 MAPK kinase, partially attenuated the ET-1 (10 nM)-induced contraction in WKY and SHR (Fig. 1: A and B) . SB203580 (10 mM), an inhibitor of p38 MAPK, (20) also partially attenuated the ET-1 (10 nM)-induced contraction in WKY (Fig. 2A) . In contrast, SB203580 (10 mM) completely attenuated the ET-1 (10 nM)-induced contraction in SHR (Fig. 2B) . Thus, p38 MAPK rather than p42 / p44 MAPK may be important for the regulation of the ET-1-induced vasoconstriction in SHR.
p42 / p44 MAPK are activated by phosphorylation within their activation lip at Thr 183 -Glu-Tyr 185 (21) . p38 MAPK is activated by the phosphorylation at a Thr-GlyTyr motif (22 -24) . In this study, we determined whether ET-1 increased the phosphorylation of p42 / p44 MAPK and/ or p38 MAPK in WKY and SHR aortic smooth muscle. We also determined whether PD98059 and SB203580 inhibited the ET-1-induced phosphorylation of p42 / p44 MAPK and p38 MAPK in WKY and SHR, respectively. ET-1 (10 nM) increased the phosphorylation of p42 / p44 MAPK significantly in both WKY and SHR (Fig. 3: A and B) . PD98059 (100 m M) abolished the phosphorylation of p42 / p44 MAPK induced by ET-1 to the resting levels in both WKY and SHR. On the other hand, ET-1 (10 nM) increased p38 MAPK phosphorylation significantly in both WKY and SHR (Fig. 4: A and B) . In SHR aortic smooth muscle, the ET-1-induced increase of p38 MAPK phosphorylation was significantly higher than that of WKY. SB203580 (10 m M) abolished the phosphorylation of p38 MAPK induced by ET-1 to the resting levels. These results suggest that ET-1 may evoke contraction resulting from an activation of p38 MAPK as well as p42 / p44 MAPK in both WKY and SHR. However, although PD98059 and SB203580 completely inhibited the phosphorylation of p42 / p44 MAPK and p38 MAPK by ET-1 in WKY, respectively, the contractility by ET-1 was partially attenuated in WKY. Our previous report showed that MAPK partially regulated ET-1-induced contractions in Sprague-Dawley rats (25) . Therefore, p42 / p44 MAPK and / or p38 MAPK may not be the sole regulatory kinase(s) for ET-1-induced vascular smooth muscle contraction in WKY. On the other hand, ET-1 significantly increased the phosphorylation of p38 MAPK more in SHR than in WKY. Moreover, SB203580 completely abolished the phosphorylation of p38 MAPK by ET-1 as well as the contractility by ET-1 in SHR. These results suggest that p38 MAPK activation may play an important role for the ET-1-induced vasoconstriction in SHR.
SB203580 did not affect the phosphorylation of MLC by ET-1 in either WKY or SHR (Fig. 5: A and B) . Although Ca
2+
-and calmodulin-dependent phosphorylation of the 20 kDa MLC is widely believed to be essential for the initiation of smooth muscle contraction (26) , additional regulatory pathways have been proposed to account for the maintenance of muscular force because stimulation-induced MLC phosphorylation levels are increased only transiently while force is maintained (27 -29) . Our previous report showed that tyrosine kinase participated in vasoconstriction through a Ca
-and MLC phosphorylation-independent pathway (30) . Because tyrosine kinase is an upstream regulator of MAPK, MLC may not be the major substrate for the tyrosine kinase-MAPK signaling pathway. On the other hand, caldesmon, a protein found on actin-based filaments of cells, inhibits the ATPase activity of actomyosin (31) , and is the substrate for MAPK during vasoconstriction (32, 33) . The p38 MAPK / heat shock protein (HSP)-27 pathway was suggested to be involved in the generation of maximal force in smooth muscle (15) . Recently, we have reported that caldesmon phosphorylation following p38 MAPK activation is important for the maintenance of ET-1-induced vasoconstriction in deoxycorticosterone acetate salt hypertensive rat (34) .
In conclusion, p42 / p44 MAPK and/ or p38 MAPK partially regulates the ET-1-induced vasoconstriction in WKY. However, p38 MAPK, rather than p42 / p44 MAPK, activation plays an important role for the maintenance of ET-1-induced vasoconstriction in SHR through a MLC phosphorylation-independent pathway. 
